DOI QR코드

DOI QR Code

Prevalence of corticosteroid-induced cataracts in children with nephrotic syndrome: a cross-sectional study in Pakistan

  • Saima Kashif (Department of Pediatric Nephrology, The Kidney Centre Post Graduate Training Institute) ;
  • Khemchand N. Moorani (Department of Pediatric Nephrology, The Kidney Centre Post Graduate Training Institute)
  • Received : 2025.12.05
  • Accepted : 2026.01.26
  • Published : 2026.02.28

Abstract

Purpose: Idiopathic nephrotic syndrome (NS) often necessitates prolonged or repeated corticosteroid treatment, which increases the risk for steroid-induced posterior subcapsular cataract (SI-PSC). Previous research on its burden remains limited. Here, we aimed to determine the prevalence and predictive risk factors of SI-PSC in children with NS. Methods: This cross-sectional study was conducted in the Pediatric Nephrology Department of The Kidney Centre, Karachi, Pakistan, from October 2023 to October 2025. The study included 150 children with NS, aged 2-16 years, who had received oral prednisolone for more than 6 months. Demographic and clinical information were collected through caregiver interviews and medical record review. All participants underwent a detailed slit-lamp examination by the same ophthalmologist. Associations between cataract formation and demographic or treatment-related variables were analyzed statistically. A P-value of ≤0.05 was considered significant. Results: Cataracts were detected in 23 children (15.3%). Most patients had early lenticular changes, but only two required surgical intervention. Other ocular abnormalities were uncommon (4.7%). Cataracts occurred more frequently in males and in children younger than 10 years. Cumulative corticosteroid doses were nearly identical in patients with and without cataracts. Children with frequently relapsing NS accounted for the highest proportion of those with SI-PSC. Systemic hypertension was the adverse effect most strongly associated with cataract development. Conclusions: SI-PSC is a notable complication in children receiving long-term corticosteroid therapy. Our findings underscore the importance of routine ophthalmologic screening. Individual susceptibility, including potential genetic factors, might play a role in cataract development and warrant further investigation.

Keywords

References

  1. Trautmann A, Boyer O, Hodson E, Bagga A, Gipson DS, Samuel S, et al. IPNA clinical practice recommendations for the diagnosis and management of children with steroid-sensitive nephrotic syndrome. Pediatr Nephrol 2023;38:877-919. https://doi.org/10.1007/s00467-022-05739-3
  2. Karakaya D, Gungor T, Kargin Cakici E, Yazilitas F, Celikkaya E, Bulbul M, et al. Complications related to childhood idiopathic nephrotic syndrome, its treatment and the associated risks in patients. Cureus 2023;15:e43929.
  3. Gaur S, Joseph M, Nityanandam S, Subramanian S, Koshy AS, Vasudevan A, et al. Ocular complications in children with nephrotic syndrome on long term oral steroids. Indian J Pediatr 2014;81:680-3. https://doi.org/10.1007/s12098-014-1338-2
  4. Deiaeldin YA, Elsharkawy MM, Abdelrahman HM, Omar KAA, AlNaimy MA. Incidence of cataract and glaucoma in children with nephrotic syndrome undergoing steroid treatment. J Egypt Ophthalmol Soc 2023;116:270-6. https://doi.org/10.4103/ejos.ejos_68_23
  5. Nakubulwa F, Lusobya RC, Batte A, Ssuna B, Nakanjako D, Nakiyingi L, et al. Prevalence and predictors of ocular complications among children undergoing nephrotic syndrome treatment in a resource-limited setting. BMC Ophthalmol 2021;21:55. https://doi.org/10.1186/s12886-021-01817-6
  6. Olonan LR, Pangilinan GA, Yatco MM. Steroid-induced cataract and glaucoma in pediatric patients with nephrotic syndrome. Philipp J Ophthalmol 2009;34:59-62.
  7. Jian YF, Zhang JS, Wan XH. Cataract induced by glucocorticoids. Clin Ophthalmol 2025;19:3703-12. https://doi.org/10.2147/OPTH.S537700
  8. Ng JS, Wong W, Low RW, Hui J, Wong EN, Lam DS. Ocular complications of pediatric nephrotic syndrome. Clin Exp Ophthalmol 2001;29:239-43. https://doi.org/10.1046/j.1442-9071.2001.00426.x
  9. Zulfiqar Z, Lanewala F, Khatri S, Bajeer I, Aziz M, Hashmi S. Steroid induced ocular complications in idiopathic nephrotic syndrome: a cross-sectional single-center study. J Pak Med Assoc 2024;74:315-9. https://doi.org/10.47391/JPMA.10573
  10. Kalra S, Sharma A, Bamal M, Bhandari S, Dhillon M. A pilot study to determine the serum levels of insulin, leptin and adiponectin in obese children with steroid resistant and dependent nephrotic syndrome. Int J Nephrol Res 2024;6:37-41.
  11. Shabbir K, Anjum M, Naeem B, Urooj H. Frequency of posterior cataract in steroid-dependent or frequent relapse nephrotic syndrome in children. Prof Med J 2023;30:1436-41.
  12. Hayasaka Y, Hayasaka S, Matsukura H. Ocular findings in Japanese children with nephrotic syndrome receiving prolonged corticosteroid therapy. Ophthalmologica 2006;220:181-5. https://doi.org/10.1159/000091762
  13. Zhao Y, Su BG, Xiao HJ, Zhang HW, Liu XY, Wang F, et al. Clinical characteristics of glucocorticoid-induced eye adverse reactions in children with primary nephrotic syndrome. Beijing Da Xue Xue Bao Yi Xue Ban 2017;49:794-7.
  14. Oh GJ, Waldo A, Paez-Cruz F, Gipson PE, Pesenson A, Selewski DT, et al. Steroid-associated side effects in patients with primary proteinuric kidney disease. Kidney Int Rep 2019;4:1608-16. https://doi.org/10.1016/j.ekir.2019.08.019
  15. Behar-Cohen F, Zhao M. Mineralocorticoid pathway in retinal health and diseases. Br J Pharmacol 2022;179:3190-204. https://doi.org/10.1111/bph.v179.13
  16. Toruan YM, Trihono PP, Sitorus RS, Dwipoerwantoro PG. Ocular complications in pediatric nephrotic syndrome treated with corticosteroids. Paediatr Indones 2024;64:1-9. https://doi.org/10.14238/pi64.1.2024
  17. Hariharan R, Krishnamurthy S, Kaliaperumal S, Karunakar P, Deepthi B. Incidence and predictive risk factors for ophthalmological complications in children with nephrotic syndrome receiving longterm oral corticosteroids: a cohort study. Paediatr Int Child Health 2021;41:199-205. https://doi.org/10.1080/20469047.2021.1983315
  18. Ahmed A, Wesam EA, Mohamed SS, Mahmoud A. Ocular parameter changes in pediatric patients with nephrotic syndrome. Med J Cairo Univ 2021;89:1453-8.
  19. Chaudhury GN, Khandaker T, Ferdous T, Chowdhury RA, Afroz S, Hanif M, et al. Ocular and extra-ocular complications following long-term steroid consumption in children with idiopathic nephrotic syndrome. BIRDEM Med J 2021;11:7-10. https://doi.org/10.3329/birdem.v11i1.51023
  20. Yan H, Tan X, Yu J, Liang T, Shi W, Li L, et al. The occurrence timeline of steroid-induced ocular hypertension and cataract in children with systemic autoimmune diseases. Int Ophthalmol 2022;42:2175-84. https://doi.org/10.1007/s10792-022-02217-5
  21. Agrawal V, Devpura K, Mishra L, Agarwal S. Study on steroid induced ocular findings in children with nephrotic syndrome. J Clin Diagn Res 2017;11:SC05-6. https://doi.org/10.7860/JCDR/2017/24694.9334
  22. Lee JM, Kronbichler A, Shin JI, Oh J. Review on long-term non-renal complications of childhood nephrotic syndrome. Acta Paediatr 2020;109:460-70. https://doi.org/10.1111/apa.v109.3
  23. Eid R, Fathy AA, Hamdy N. Health-related quality of life in Egyptian children with nephrotic syndrome. Qual Life Res 2020;29:2185-96. https://doi.org/10.1007/s11136-020-02438-0
  24. Aydin M, Franke I, Kurylowicz L, Ganschow R, Lentze M, Born M, et al. The long-term outcome of childhood nephrotic syndrome in Germany: a cross-sectional study. Clin Exp Nephrol 2019;23:676-88. https://doi.org/10.1007/s10157-019-01696-8
  25. Fournier C, Milot JA, Clermont MJ, O'Regan S. The concept of corticosteroid cataractogenic factor revisited. Can J Ophthalmol 1990;25:345-7.
  26. James ER, Fresco VM, Robertson LL. Glucocorticoid-induced changes in the global gene expression of lens epithelial cells. J Ocul Pharmacol Ther 2005;21:11-27. https://doi.org/10.1089/jop.2005.21.11
  27. Zhou D, Zhang Y, Wang L, Sun Y, Liu P. Identification of genes and transcription factors associated with glucocorticoid response in lens epithelial cells. Mol Med Rep 2015;11:4073-8. https://doi.org/10.3892/mmr.2015.3308
  28. Shi Z, Zhao X, Su Y, Wang C, Liu P, Ge H, et al. Screening of biological target molecules related to glucocorticoid-induced cataract (GIC) on the basis of constructing ceRNA network. Biochem Genet 2022;60:24-38. https://doi.org/10.1007/s10528-021-10078-3